BRITISH CANNABIS™, registered as CBD Health Foods Ltd, is delighted to become the first company to receive confirmation from the Food Standards Agency UK (FSA) that its cannabis-derived products will remain on the market.
On Thursday 13th January 2022, the FSA confirmed via emails to BRITISH CANNABIS CEO, Thomas Whettem, that the evidence submitted in support of 15 dossiers, spanning over 3,000 products “has been checked and is sufficient” and that “the public list will be amended to reflect these changes”.
BRITISH CANNABIS’ own-brand products - CBD by BRITISH CANNABIS™ (FKA Canabidol™), Access CBD™ and CBD HEALTH™ - plus over 150 other brands that they manufacture for, look set to remain on the UK market. Meanwhile, it is widely speculated that an as-yet undetermined number of other products, made by other manufacturers, will be removed from shelves by Trading Standards. This process looks set to begin once the FSA public lists are updated later in 2022.
Robert Jappie, partner at legal firm Ince and preeminent cannabis industry lawyer, remarked at the news: “I’m delighted that BRITISH CANNABIS has received a positive response from the FSA to their Novel Food submission. Admission of BRITISH CANNABIS’ products to the compliance registers confirms the company’s position at the forefront of the U.K. CBD industry. Novel Food compliance should now provide a platform for the sector to build on its fantastic success to date.”
Over the course of 18 months and a multi-million pound investment, BRITISH CANNABIS, whose brands are stocked across many pharmacies and retailers internationally, have dedicated themselves to ensuring the long-term continuity of all-natural, cannabis-based food supplements in the UK. This is for the reassurance of their own consumers and of all the customers whose brands are Powered by BRITISH CANNABIS.
Making this achievement of particular note is the fact that BRITISH CANNABIS products are among the few remaining on the market to use ‘100% Cannabis sativa L.”, naturally derived formulas, thus they contain the hundreds of clinically proven plant phytochemicals found in cannabis, whilst also being 0% THC, meaning that they will not cause a “high”. Their food supplements (CBD oils, capsules etc.) are also free from other controlled cannabinoids.
BRITISH CANNABIS’ CEO, Thomas Whettem, reacted shortly after hearing the great news: “Confirmation directly from the Food Standards Agency, that BRITISH CANNABIS will be the first manufacturer in the world to have cannabis-derived consumer products ratified by the UK government, is yet another monumental breakthrough in our history. For years we have not just pioneered change in this industry but strived to set the bar when it comes to compliance, safety and the simple dedication to excellence we have had since day one.”
BRITISH CANNABIS’ Managing Director, David Ralson, commented on this landmark news: “This is a huge milestone for our business and the Cannabis industry as a whole. I would firstly like to pay testimony to our staff, who over the past 6 years have endeavoured to make BRITISH CANNABIS the leading legal-cannabis experts in our sector and this exemplifies our phrase ‘’We Know More, Because We Do More’’.
We have always believed in wholly cannabis-derived, natural products and obtaining the highest quality standards. This is underpinned by our own retail brands, which to date have received over 4,200 Trustpilot reviews with a 5-Star rating!
This also paves the way for our trusted white label partners brands, who continue to work with us, to also remain on the UK market. This allows our business and its compliant partners to continue to grow in what is going to be a very exciting year indeed!”
At time of release, the Novel Foods pubic lists have yet to be updated.
BRITISH CANNABIS™ can be reached on +44 (0) 203 965 2420 or via email at email@example.com
BRITISH CANNABIS™ - A UK CBD Industry Original
BRITISH CANNABIS™ is the largest producer, manufacturer, and distributor of legal cannabis-derived products in the UK. They own and operate a unique extraction and purification facility in England and provide analytical testing, bulk extracts and white label products to the UK market leading brands.
With over a thousand CBD food supplement products, included across no less than 15 thorough applications to the Food Standards Agency, the makers of Canabidol™, ACCESS CBD™ and many successful white label brands are set to bring cannabis-based wellness products to the people for years to come.
Press release distributed by Pressat on behalf of British Cannabis, on Friday 14 January, 2022. For more information subscribe and follow https://pressat.co.uk/